×
Choose Speciality

EXPLORE!

LOGIN

By signing up or signing in to eMediNexus, you consent to eMediNexus collecting and using your personal data in accordance with our Privacy Policy. We are committed to safeguarding your information and ensuring the highest standards of data protection. Your trust and privacy are of utmost importance to us.

Response with omalizumab varies by asthma type

  230 Views

eMediNexus    13 October 2017

A multicenter, retrospective study, presented at the European Academy of Allergy and Clinical Immunology Congress 2017, suggests that the benefit of omalizumab is greater in patients who have early-onset allergic asthma or severe asthma with frequent exacerbations as compared to those who have other asthma phenotypes.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.